XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
EQUITY AWARDS (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the nine months ended September 30, 2023 and 2022 follows:

Nine Months Ended September 30, 2023

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

497,820

 

 

$

28.07

 

 

 

5.87

 

 

$

3,402

 

Granted

 

 

41,500

 

 

 

28.44

 

 

 

 

 

 

 

Exercised

 

 

(21,440

)

 

 

24.05

 

 

 

 

 

 

 

Forfeited

 

 

(48,450

)

 

 

30.62

 

 

 

 

 

 

 

Balance, September 30, 2023

 

 

469,430

 

 

$

28.02

 

 

 

5.53

 

 

$

1,228

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

268,030

 

 

$

25.87

 

 

 

3.96

 

 

$

956

 

 

Nine Months Ended September 30, 2022

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

502,780

 

 

$

25.77

 

 

 

5.59

 

 

$

5,936

 

Granted

 

 

69,000

 

 

 

35.71

 

 

 

 

 

 

 

Exercised

 

 

(43,280

)

 

 

22.56

 

 

 

 

 

 

 

Forfeited

 

 

(29,920

)

 

 

27.21

 

 

 

 

 

 

 

Balance, September 30, 2022

 

 

498,580

 

 

$

27.34

 

 

 

5.62

 

 

$

3,725

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

283,910

 

 

$

24.96

 

 

 

4.20

 

 

$

2,733

 

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the nine months ended September 30, 2023 and 2022 follows:

Nine Months Ended September 30, 2023

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

216,480

 

 

$

5.95

 

Granted

 

 

41,500

 

 

 

5.82

 

Vested

 

 

(35,860

)

 

 

5.82

 

Forfeited

 

 

(20,720

)

 

 

12.41

 

Balance, September 30, 2023

 

 

201,400

 

 

$

5.95

 

 

Nine Months Ended September 30, 2022

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

207,084

 

 

$

5.23

 

Granted

 

 

69,000

 

 

 

6.56

 

Vested

 

 

(46,014

)

 

 

5.90

 

Forfeited

 

 

(15,400

)

 

 

9.09

 

Balance, September 30, 2022

 

 

214,670

 

 

$

5.53

 

Plan Information

Information related to stock options in the Plan is as follows for the nine months ended:

 

 

September 30, 2023

 

 

September 30, 2022

 

Intrinsic value of options exercised

 

$

99

 

 

$

521

 

Cash received from options exercised

 

 

516

 

 

 

976

 

Weighted average fair value of options granted

 

 

5.82

 

 

 

6.56

 

 

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the nine months ended September 30, 2023 and 2022 follows:

Nine Months Ended September 30, 2023

 

Number of
Shares

 

 

Weighted-Average
 Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

18,930

 

 

$

27.51

 

Granted

 

 

2,056

 

 

 

34.10

 

Vested

 

 

(3,670

)

 

 

28.57

 

Forfeited

 

 

(1,076

)

 

 

28.93

 

Balance, September 30, 2023

 

 

16,240

 

 

$

28.02

 

Nine Months Ended September 30, 2022

 

Number of
Shares

 

 

Weighted-Average
Grant
 Date Fair Value

 

Outstanding at beginning of year

 

 

30,190

 

 

$

27.52

 

Vested

 

 

(4,770

)

 

 

28.32

 

Balance, September 30, 2022

 

 

25,420

 

 

$

27.37